Zantac (generic: Ranitidine) has been on the market for decades as a trusted heartburn relief medication. Available over the counter and with a prescription, the drug was used by millions of people across the country. Tragically, it was discovered that a chemical in Zantac, called NDMA, could lead to cancer. NDMA is highly-dangerous when consumed in high doses. Zantac is one of several heartburn medications to be voluntarily recalled due to the risk of carcinogen exposure. If you have heartburn medication in your possession, we urge you to speak to your doctor to ensure that the drug you are taking is safe. After much research, the link between Zantac and cancer became more prevalent, and it is believed to have caused the development of cancer in patients who took the drug regularly over an extended period of time.
Zantac has been linked to many cancers, not just one or two specific types. Below you will find a brief list of some of the cancers:
Please keep in mind that simply developing cancer after taking Zantac is not enough to prove the medication caused it. There are a number of possible indicators to consider, including dietary, environmental, and genetic factors. We know you want answers as to what caused the illness, and your oncologist may be able to narrow down the possibilities. Talk to your doctor about your concerns related to your history with Zantac.If you suspect that your cancer may have been caused by regular, extended use of Zantac, begin searching for a skilled product liability attorney in your area. The law firm will need details about your health history, Zantac usage, and more. Some questions you may be asked are:
It is helpful for you to know information about your treatment, like the type and stage of your cancer, the diagnostic tests performed, and where you will be receiving treatment. If you have already completed your treatment and are in recovery, request your medical records. It is also important to be forthcoming about health issues like smoking history, other illnesses and medications you manage, and your personal and familial cancer history.Having this information can expedite the process of having the case reviewed by the attorneys. This consultation is at no cost to you. To have your case reviewed by our experienced team at Scartelli Olszewski, call or message us.
Peter Paul Olszewski, Jr., a shareholder and managing partner at Scartelli Olszewski, P.C., brings 37 years of litigation experience. He is a renowned trial lawyer in Pennsylvania, specializing in medical malpractice, personal injury, and criminal defense. Peter's notable achievements include securing multi-million-dollar verdicts and serving as District Attorney and Judge. He is committed to community involvement and is actively engaged in various legal associations.
Linked In - https://www.linkedin.com/in/peter-paul-olszewski-jr-11115b1a/